1.1 What a Clinical Trial Protocol Must Achieve
1.2 Linking Protocol Design to the Development Strategy
1.3 Protocol Design Team, Roles, and Decision Rights
1.4 Governance Cadence, Review Cycles, and Sign-Offs
1.5 Protocol Design Checklist
2.1 Translating the Scientific Hypothesis Into Trial Objectives
2.2 Primary, Secondary, Exploratory, and Safety Endpoints
2.3 Endpoint Selection Tradeoffs and Evidence Standards
2.4 Endpoint Timing, Measurement, and Assessment Methods
2.5 Endpoint Selection Template
3.1 Defining the Target Patient Population
3.2 Inclusion Criteria: Precision, Feasibility, and Generalizability
3.3 Exclusion Criteria: Safety, Bias, and Recruitment Impact
3.4 Subgroups, Stratification, and Enrichment Strategies
3.5 Eligibility Criteria Review Checklist
4.1 Choosing the Right Trial Design
4.2 Treatment Arms, Control Groups, and Randomization Logic
4.3 Visit Schedule, Assessments, and Patient Burden
4.4 Safety Monitoring, Stopping Rules, and Rescue Therapy
4.5 Schedule of Activities Design Template
5.1 Sample Size Logic and Key Assumptions
5.2 Power, Effect Size, Variability, and Dropout Rates
5.3 Analysis Populations and Statistical Endpoints
5.4 Interim Analyses, Multiplicity, and Sensitivity Testing
5.5 Statistical Design Review Checklist
6.1 Protocol Complexity and Operational Burden
6.2 Site Feasibility, Recruitment, and Screening Funnel Logic
6.3 Patient Experience, Retention, and Visit Practicality
6.4 Lab, Imaging, Vendor, and Data Flow Feasibility
6.5 Operational Feasibility Assessment Template
7.1 Critical-to-Quality Factors in Protocol Design
7.2 Common Protocol Risks and Failure Modes
7.3 Risk Mitigation, Monitoring, and Escalation Controls
7.4 Protocol Review, Amendment Prevention, and Final Approval
7.5 Protocol Risk Register Template
8.1 When to Engage External Advisors
8.2 Support From Large Consulting Firms
8.3 CROs, Biostatisticians, Medical Writers, and Functional Experts
8.4 Independent Management Consultants Through Umbrex
8.5 Advisor Selection and Engagement Checklist
